What are the treatment recommendations for a patient with a right lower extremity moderate focal stenosis, a proximal common iliac artery mural thrombus, moderate multifocal stenosis of the superficial femoral artery, a moderate‑severe focal stenosis in the adductor canal, a peripheral mural thrombus, and a penetrating ulcer?

Immediate Endovascular Revascularization with Anticoagulation

This patient requires urgent endovascular revascularization targeting the common iliac artery mural thrombus and stenotic lesions, combined with systemic anticoagulation, given the presence of acute thrombotic disease with a penetrating ulcer that signals high risk for limb loss and systemic embolization.

Treatment Algorithm

1. Immediate Management (Within 24-48 Hours)

Anticoagulation:

• Start therapeutic anticoagulation immediately (unfractionated heparin or LMWH) to prevent thrombus propagation and embolization from the mural thrombi
• The penetrating ulcer in the arterial wall creates additional embolic risk requiring urgent stabilization

Vascular Surgery/Interventional Consultation:

• Emergent consultation given the combination of mural thrombus and penetrating ulcer, which represents unstable plaque with high complication risk

2. Revascularization Strategy (Proximal to Distal)

Common Iliac Artery (Mural Thrombus + Stenosis):

• Primary stenting is indicated for the common iliac artery stenosis 1
• The mural thrombus requires either:
  • Aspiration thrombectomy prior to stenting if substantial thrombus burden exists
  • Covered stent placement to trap thrombus against vessel wall and exclude the penetrating ulcer
• Balloon-expandable stents are preferred in the common iliac artery for their radial strength and precise placement 2

Superficial Femoral Artery (Multifocal Stenosis):

• Drug-eluting balloon angioplasty or drug-eluting stents should be the first-line approach for the SFA lesions 3
• Primary nitinol stenting is recommended for intermediate-length SFA lesions, providing 20-30% lower restenosis rates than angioplasty alone at 1-2 years 2
• Avoid primary stenting if lesions are very short (<5cm focal) where balloon angioplasty alone may suffice

Adductor Canal (Moderate-Severe Focal Stenosis):

• Provisional stenting strategy: Initial balloon angioplasty with stent placement only if suboptimal result (residual stenosis >50%, flow-limiting dissection, or persistent pressure gradient) 1
• The adductor canal is a high-flexion zone where stent fracture risk is elevated; use latest-generation nitinol stents if stenting required 2

Peripheral Mural Thrombus:

• Address with aspiration thrombectomy during the same intervention
• Ensure adequate anticoagulation maintained throughout procedure

3. Critical Technical Considerations

Pressure Gradient Assessment:

• Obtain translesional pressure gradients (with vasodilation) for the iliac stenosis to confirm hemodynamic significance before intervention 1
• Do not intervene if no significant gradient despite vasodilation 1

Penetrating Ulcer Management:

• This is the highest-risk feature requiring covered stent consideration in the iliac segment
• The ulcer represents unstable plaque that can rupture or embolize

Avoid These Pitfalls:

• Do NOT use primary stenting in the SFA/adductor canal without attempting balloon angioplasty first (unless using drug-eluting technology) 1
• Do NOT delay intervention—the combination of mural thrombus and penetrating ulcer creates acute risk
• Do NOT treat this as simple claudication; the thrombotic burden and ulcer indicate unstable disease

4. Post-Procedure Management

Anticoagulation Duration:

• Continue therapeutic anticoagulation for minimum 3-6 months given the mural thrombi
• Transition to dual antiplatelet therapy (aspirin + clopidogrel) after acute thrombotic risk resolves
• Long-term single antiplatelet therapy indefinitely

Statin Therapy:

• High-intensity statin regardless of baseline lipid levels 4

Surveillance:

• Duplex ultrasound at 1,3,6, and 12 months post-intervention to detect restenosis
• ABI measurements at each visit
• Clinical assessment for symptom recurrence

5. Alternative Consideration: Hybrid Approach

If endovascular approach fails or anatomy is prohibitive:

• Common femoral endarterectomy (if disease extends to CFA) combined with iliac stenting
• Femoral-popliteal bypass with autogenous vein if SFA lesions cannot be adequately treated endovascularly

However, given the acute thrombotic component, endovascular-first strategy is strongly preferred to minimize surgical trauma and allow for immediate thrombus management 2, 4.

Key Point on Urgency

The presence of mural thrombus with penetrating ulcer distinguishes this from routine PAD—this represents acute-on-chronic disease with embolic and rupture risk. While guidelines focus on claudication vs. CLTI, your patient has features suggesting impending acute limb ischemia that mandate urgent (not elective) intervention regardless of symptom severity 5, 3.